Medicenna Therapeutics Corp. - COM (MDNAF)

CUSIP: 58490H107

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COM
Total 13F shares
8,762,397
Share change
-832,866
Total reported value
$5,596,089
Price per share
$0.63
Number of holders
26
Value change
-$399,184
Number of buys
6
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 58490H107?
CUSIP 58490H107 identifies MDNAF - Medicenna Therapeutics Corp. - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Medicenna Therapeutics Corp. - COM (MDNAF) as of Q1 2023

As of 31 Mar 2023, Medicenna Therapeutics Corp. - COM (MDNAF) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,762,397 shares. The largest 10 holders included AIGH Capital Management LLC, Worth Venture Partners, LLC, Hudson Bay Capital Management LP, DAFNA Capital Management LLC, Verition Fund Management LLC, Sigma Planning Corp, LETKO, BROSSEAU & ASSOCIATES INC, RENAISSANCE TECHNOLOGIES LLC, Royal Bank of Canada, and Rathbones Group PLC. This page lists 26 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.